1. 1606PDQuality of life in patients with soft tissue sarcoma undergoing palliative treatment: A multicenter, cluster-randomized trial within the Germany Interdisciplinary Sarcoma Group (GISG-12). (23rd October 2018) Authors: Hentschel, L; Richter, S; Kopp, H-G; Kasper, B; Kunitz, A; Grünwald, V; Kessler, T; Chemnitz, J-M; Pelzer, U; Schuler, U S; Freitag, J; Schilling, A; Hornemann, B; Arndt, K; Ehninger, G; Bornhäuser, M; Schuler, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.013 Long-term analyses of the NOA-08 randomized phase III trial of temozolomide versus radiotherapy for elderly patients with malignant astrocytomas. (19th September 2018) Authors: Wick, A; Kessler, T; Platten, M; Meisner, C; Bamberg, M; Herrlinger, U; Felsberg, J; Weyerbrock, A; Seidel, C; Steinbach, J P; Sabel, M; Vesper, J; Debus, J; Sahm, F; Meixensberger, J; Ketter, R; Mayer-Steinacker, R; von Deimling, A; Reifenberger, G; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS3.5 Dynamic insights into the cellular heterogeneity of malignant gliomas. (19th September 2018) Authors: Xie, R; Kessler, T; Grosch, J; Huang, L; Solecki, G; Wick, W; Winkler, F Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P01.013 Long-term analyses of the NOA-08 randomized phase III trial of temozolomide versus radiotherapy for elderly patients with malignant astrocytomas. (19th September 2018) Authors: Wick, A; Kessler, T; Platten, M; Meisner, C; Bamberg, M; Herrlinger, U; Felsberg, J; Weyerbrock, A; Seidel, C; Steinbach, J P; Sabel, M; Vesper, J; Debus, J; Sahm, F; Meixensberger, J; Ketter, R; Mayer-Steinacker, R; von Deimling, A; Reifenberger, G; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P04.30 Methadone does not increase toxicity of temozolomide in glioblastoma cells. (19th September 2018) Authors: Latzer, P; Kessler, T; Sahm, F; Rübmann, P; Hielscher, T; Platten, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk. (3rd October 2022) Authors: Lahu, S; Presch, A; Ndrepepa, G; Bernlochner, I; Joner, M; Xhepa, E; Kufner, S; Sager, H B; Mayer, K; Kessler, T; Laugwitz, K L; Schunkert, H; Neumann, F J; Kastrati, A; Cassese, S Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. JS08.6.A A connectivity signature for glioblastoma. (5th September 2022) Authors: Hoffmann, D C; Hai, L; Wagener, R; Mandelbaum, H; Xie, R; Hausmann, D; Dominguez Azorín, D; Weil, S; Sievers, P; Cebulla, G; Ito, J; Warnken, U; Venkataramani, V; Ernst, K; Reibold, D; Will, R; Suvà, M L; Herold-Mende, C; Sahm, F; Winkler, F Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P04.04 Optimizing dasatinib for glioblastoma treatment. (9th September 2021) Authors: Alhalabi, O; Göttmann, M; Gold, M; Fletcher, M; Hielscher, T; Iskar, M; Kessler, T; Wittmann, E; Schlue, S; Rahman, S; Hai, L; Hansen-Palmus, L; Puccio, L; Nakano, I; Herold-Mende, C; Baumgartner, U; Day, B; Wick, W; Sahm, F; Fraenkel, E Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P11.07 LAPTM5 functions as a tumor suppressor via CD40 - NFêB pathway inhibition and represents a potential biomarker for temozolomide sensitivity in CD40 proficient glioblastoma. (6th September 2019) Authors: Berberich, A; Bartels, F; Tang, Z; Pusch, S; Hucke, N; Kessler, T; Dong, Z; Wiestler, B; Winkler, F; Platten, M; Wick, W; Abdollahi, A; Lemke, D Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P04.62 The oncometabolite R-2-Hydroxyglutarate suppresses the innate immune microenvironment of IDH1-mutated gliomas via aryl hydrocarbon receptor signaling. (19th September 2018) Authors: Friedrich, M; Bunse, L; Bunse, T; Green, E; Kessler, T; Pusch, S; Sanghvi, K; Carretero, R; Gutcher, I; von Deimling, A; Wick, W; Platten, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗